Last updated: January 16, 2025
Sponsor: Odense University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Placebo
GLP-1 hormone
Clinical Study ID
NCT06722560
S--20240027
Ages 18-40 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Healthy
Exclusion
Exclusion Criteria:
Diabetes mellitus including prediabetes (Hb1Ac >42 mmol/mol at baseline)
BMI > 28 kg/m2
Conditions and pharmaceutical treatments that influence bone metabolism (e.g., bonefractures < 6 months, uncontrolled thyrotoxicosis, and severe renal impairment).
Pregnancy
Inability to complete all investigations or to provide informed consent
Study Design
Total Participants: 12
Treatment Group(s): 2
Primary Treatment: Placebo
Phase:
Study Start date:
January 07, 2025
Estimated Completion Date:
January 01, 2026
Connect with a study center
Department of Endocrinology, University Hospital of Odense
Odense, 5000
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.